Stryker Corporation $SYK Shares Acquired by QRG Capital Management Inc.

Key Points

• QRG Capital Management increased its stake in Stryker by 7.4% to 60,548 shares, valued at about $21.28 million, and institutional investors now own roughly 77.09% of the company.
• Director Ronda E. Stryker sold 250,000 shares at an average of $362.92 for about $90.73 million, reducing her position by 9.23%; corporate insiders own ~4.60% of Stryker.
• Stryker missed the quarter with EPS $2.60 vs. $2.98 expected and revenue of $6.02B vs. $6.34B expected, but issued FY2026 guidance of $14.90–$15.10 EPS and carries a sell‑side consensus rating of "Moderate Buy" (consensus target ~$395.48).

QRG Capital Management Inc. increased its position in Stryker Corporation (NYSE:SYK - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,548 shares of the medical technology company's stock after acquiring an additional 4,186 shares during the period. QRG Capital Management Inc.'s holdings in Stryker were worth $21,281,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. United Financial Planning Group LLC acquired a new stake in shares of Stryker in the 3rd quarter worth approximately $27,000. Strive Asset Management LLC acquired a new stake in shares of Stryker in the 3rd quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Stryker in the 3rd quarter worth approximately $34,000. Copia Wealth Management grew its holdings in shares of Stryker by 181.6% in the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company's stock worth $40,000 after acquiring an additional 69 shares during the period. Finally, Ares Financial Consulting LLC acquired a new stake in shares of Stryker in the 4th quarter worth approximately $40,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the transaction, the director owned 2,457,331 shares of the company's stock, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 4.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

SYK has been the topic of a number of research reports. Jefferies Financial Group restated a "buy" rating and issued a $465.00 price target on shares of Stryker in a report on Wednesday, March 4th. Piper Sandler restated an "overweight" rating on shares of Stryker in a report on Tuesday, January 27th. Needham & Company LLC reduced their target price on Stryker from $454.00 to $418.00 and set a "buy" rating on the stock in a research note on Friday. Robert W. Baird set a $385.00 target price on Stryker in a research note on Friday. Finally, Wells Fargo & Company reduced their target price on Stryker from $456.00 to $418.00 and set an "overweight" rating on the stock in a research note on Friday. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $395.48.

Stryker Price Performance

SYK stock opened at $291.21 on Tuesday. Stryker Corporation has a 1 year low of $290.22 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The stock's 50 day moving average price is $345.67 and its 200 day moving average price is $356.80. The firm has a market cap of $111.53 billion, a P/E ratio of 33.70, a PEG ratio of 1.73 and a beta of 0.80.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company had revenue of $6.02 billion during the quarter, compared to analysts' expectations of $6.34 billion. During the same period in the previous year, the company posted $2.84 EPS. Stryker's quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, sell-side analysts expect that Stryker Corporation will post 14.89 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend was Tuesday, March 31st. Stryker's dividend payout ratio is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.